The Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH) is a research hub that is committed to improving substance use disorder treatment, policies, and care for people who use drugs. CHERISH is connected to more than 100 affiliated researchers across the U.S. To disseminate newly published work to researchers and policymakers, I share key findings through concise and informative research summaries and write profile series to amplify the experts in our network.
In recent years, CHERISH Research Affiliate Sabrina A. Assoumou has become a familiar face in Boston and a trusted voice in the scientific community.
An infectious diseases physician and clinician-investigator at the Boston University Chobanian & Avedisian School of Medicine and the Center for Infectious Diseases at Boston Medical Center, Assoumou appeared in local and national news to provide guidance on COVID-19 and flu vaccinations and report on racial and health disparities affecting Black communities. She is also now a 2024-2026 New Voices member at the Academies of Sciences, Engineering, and Medicine, where she convenes with interdisciplinary leaders across the nation to address emerging STEM challenges.
Assoumou is also a close collaborator with CHERISH colleagues in Boston, including CHERISH Population Data & Modeling Core Co-director Benjamin Linas, and CHERISH investigators Jake R. Morgan and Alexander Walley. Their published studies demonstrated the cost-effectiveness of providing routine hepatitis C screening in primary care settings, identified patterns of discontinuation for medications for opioid use disorder, and presented opportunities and challenges of receiving HIV and HCV testing results at detoxification centers.
Read the full story at the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH), published on June 14, 2024.